Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. [electronic resource]
Producer: 20050314Description: 17-26 p. digitalISSN:- 0364-5134
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine -- pharmacology
- 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine -- pharmacology
- Analysis of Variance
- Animals
- Antiparkinson Agents -- adverse effects
- Autoradiography -- methods
- Behavior, Animal
- Blotting, Western -- methods
- Cyclin-Dependent Kinase 5
- Cyclin-Dependent Kinases
- Disease Models, Animal
- Dopamine Plasma Membrane Transport Proteins
- Dopamine and cAMP-Regulated Phosphoprotein 32
- Dose-Response Relationship, Drug
- Drug Interactions
- Dyskinesia, Drug-Induced -- etiology
- Female
- Guanosine 5'-O-(3-Thiotriphosphate) -- pharmacokinetics
- Immunohistochemistry -- methods
- In Situ Hybridization -- methods
- Isotopes -- pharmacokinetics
- Levodopa -- adverse effects
- Macaca fascicularis
- Membrane Glycoproteins -- metabolism
- Membrane Transport Proteins -- metabolism
- Motor Activity -- drug effects
- Nerve Tissue Proteins -- metabolism
- Nortropanes -- pharmacokinetics
- Parkinsonian Disorders -- drug therapy
- Phosphoproteins -- metabolism
- Radioligand Assay -- methods
- Receptors, Dopamine D1 -- agonists
- Receptors, Dopamine D2 -- genetics
- Signal Transduction -- drug effects
- Substantia Nigra -- drug effects
- Time Factors
- Tyrosine 3-Monooxygenase -- metabolism
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.